Spots Global Cancer Trial Database for hepatitis
Every month we try and update this database with for hepatitis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation | NCT00080236 | Liver Transplan... Hepatitis Cholestasis Carcinoma, Hepa... | IDN-6556 Placebo | 18 Years - | Conatus Pharmaceuticals Inc. | |
| Protein Biomarker in Hepatocellular Carcinoma | NCT00465842 | Normal Voluntee... Hepatitis Liver Cirrhosis Hepatocellular ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | ||
| Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives | NCT05635266 | Age-Related Mac... Allergies Alpha-Gal Syndr... Alzheimer Disea... Amyloidosis Ankylosing Spon... Arthritis Alopecia Areata Asthma Atopic Dermatit... Autism Autoimmune Hepa... Behcet's Diseas... Beta-Thalassemi... Cancer Celiac Disease Kidney Diseases COPD Crohn Disease Cystic Fibrosis Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Disease... Hepatitis Hidradenitis Su... ITP Leukemia ALS Lupus or SLE Lymphoma Multiple Sclero... Myasthenia Grav... Heart Diseases Parkinson Disea... Pemphigus Vulga... Cirrhosis Psoriasis Schizophrenia Scleroderma Sickle Cell Dis... Stroke Ulcerative Coli... Vasculitis Vitiligo | Specimen sample | 18 Years - 85 Years | Sanguine Biosciences | |
| Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients | NCT02108444 | Hepatitis Hepatitis B Lymphoma Hematologic Dis... | 18 Years - 80 Years | Peking University | ||
| Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma | NCT01390194 | Underlying Live... Hepatitis Fibrosis of Liv... Cirrhosis With ... Lesion on a Pri... | 19 Years - | University of Nebraska | ||
| Protein Biomarker in Hepatocellular Carcinoma | NCT00465842 | Normal Voluntee... Hepatitis Liver Cirrhosis Hepatocellular ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | ||
| Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L | NCT02232490 | Hepatocellular ... HCC Liver Cancer | hepcortespenlis... Placebo | 18 Years - | Immunitor LLC | |
| A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer | NCT05719480 | Liver Cancer Liver Cirrhosis Fatty Liver Hepatitis | Proteomics tech... | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis | NCT04810156 | Hepatitis, Drug... | Mycophenolate M... Solu-Medrol Ursodeoxycholic... Prednisone tabl... | 18 Years - | Herlev Hospital | |
| HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I) | NCT03685708 | Hepatitis Safety and Tole... | HEPLISAV-B | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation | NCT00080236 | Liver Transplan... Hepatitis Cholestasis Carcinoma, Hepa... | IDN-6556 Placebo | 18 Years - | Conatus Pharmaceuticals Inc. | |
| Community-based Hepatitis B Interventions for Hmong Adults | NCT00888407 | Liver Cancer | HBV Screening -... Nutrition - Sma... | 18 Years - 64 Years | University of California, Davis | |
| Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients | NCT02108444 | Hepatitis Hepatitis B Lymphoma Hematologic Dis... | 18 Years - 80 Years | Peking University | ||
| HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I) | NCT03685708 | Hepatitis Safety and Tole... | HEPLISAV-B | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Validation of SMS Protocol for HCC Screening in High-risk Patients | NCT05429190 | Hepatocellular ... | Short MRI surve... Bi-annual ultra... | 18 Years - | Erasmus Medical Center | |
| Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | NCT01559844 | Hepatitis C Hepatocellular ... | Sofosbuvir Ribavirin | 18 Years - | Gilead Sciences | |
| Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma | NCT01641276 | Hepatitis Hepatocellular ... | Low intensity a... | 18 Years - | Hospital Sirio-Libanes | |
| A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer | NCT05719480 | Liver Cancer Liver Cirrhosis Fatty Liver Hepatitis | Proteomics tech... | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| Validation of SMS Protocol for HCC Screening in High-risk Patients | NCT05429190 | Hepatocellular ... | Short MRI surve... Bi-annual ultra... | 18 Years - | Erasmus Medical Center | |
| Extracellular RNA Markers of Liver Disease and Cancer | NCT02908048 | Hepatocellular ... Biliary Tract C... Cirrhosis Liver Diseases | Blood samples | 18 Years - | Mayo Clinic | |
| A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Liver Cancer | NCT05719480 | Liver Cancer Liver Cirrhosis Fatty Liver Hepatitis | Proteomics tech... | 18 Years - 70 Years | Nanfang Hospital, Southern Medical University | |
| Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant | NCT01559844 | Hepatitis C Hepatocellular ... | Sofosbuvir Ribavirin | 18 Years - | Gilead Sciences |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
